Citations (144)
Keep up to date with the latest research on this topic with citation updates for this article.
Read on this site (10)
Mabel Guzmán-Rodríguez, María Guadalupe Serna-Domínguez & Leticia Santos. (2014) Identification, heterologous expression and detection of enzymatic activity of an asparaginase from the archaeon Thermoplasma acidophilum. Biocatalysis and Biotransformation 32:5-6, pages 295-301.
Read now
Read now
Michael E Rytting. (2012) Role of L-asparaginase in acute lymphoblastic leukemia: focus on adult patients. Blood and Lymphatic Cancer: Targets and Therapy 2, pages 117-124.
Read now
Read now
Abhinav Shrivastava, Abdul
Arif Khan, Archana Shrivastav, SudhirK. Jain & PradeepK. Singhal. (2012) KINETIC STUDIES OF L-ASPARAGINASE FROM Penicillium digitatum
. Preparative Biochemistry & Biotechnology 42:6, pages 574-581.
Read now
Read now
Henk van den Berg. (2011) Asparaginase revisited. Leukemia & Lymphoma 52:2, pages 168-178.
Read now
Read now
Riccardo Masetti & Andrea Pession. (2009) First-line treatment of acute lymphoblastic leukemia with pegasparaginase. Biologics: Targets and Therapy 3, pages 359-368.
Read now
Read now
Amer Zeidan, Eunice S Wang & Meir Wetzler. (2009) Pegasparaginase: where do we stand?. Expert Opinion on Biological Therapy 9:1, pages 111-119.
Read now
Read now
Audrey M. Chen & Mark D. Scott. (2006) Comparative Analysis of Polymer and Linker Chemistries on the Efficacy of Immunocamouflage of Murine Leukocytes. Artificial Cells, Blood Substitutes, and Biotechnology 34:3, pages 305-322.
Read now
Read now
J.P. Vieira Pinheiro, C. Lanvers, G. Würthwein, R. Beier, J. Casimiro da Palma, A. von Stackelberg & J. Boos. (2002) Drug Monitoring of PEG-Asparaginase Treatment in Childhood Acute Lymphoblastic Leukemia and Non-Hodgkin's Lymphoma. Leukemia & Lymphoma 43:10, pages 1911-1920.
Read now
Read now
Fareeda Y Coxon & James Cassidy. (2000) The place of polymer prodrugs in cancer therapy. Emerging Drugs 5:4, pages 457-463.
Read now
Read now
Gregory Gregoriadis, Ana Fernandes, Brenda McCormack, Malini Mital & Xiaoqin Zhang. (1999) Polysialic Acids: Potential Role in Therapeutic Constructs. Biotechnology and Genetic Engineering Reviews 16:1, pages 203-216.
Read now
Read now
Articles from other publishers (134)
Zuzana Ciesarová & Kristína Kukurová. 2024. Acrylamide in Food. Acrylamide in Food
473
491
.
Kellen Cruvinel Rodrigues Andrade, Joel Antonio Cordeiro de Abreu, Marina Borges Guimarães, Letícia Santos Abrunhosa, Ana Luisa Leôncio Rodrigues, Yris Maria Fonseca-Bazzo, Damaris Silveira, Paula Monteiro Souza & Pérola Oliveira Magalhães. (2023) Heterologous expression of fungal L-asparaginase: a systematic review. Future Microbiology.
Crossref
Crossref
Yongsheng Gao, Maithili Joshi, Zongmin Zhao & Samir Mitragotri. (2023)
PEGylated
therapeutics in the clinic
. Bioengineering & Translational Medicine.
Crossref
Crossref
Javaraiah Parashiva, Bettadapura Rameshgowda Nuthan, Devaraju Rakshith, Chandagalu Ramesh Santhosh, Hunasanalu Kuchela Narendra Kumar & Sreedharamurthy Satish. (2023) Insights into diversity and L-asparaginase activity of fungal endophytes associated with medicinal plant Grewia hirsuta. Brazilian Journal of Microbiology 54:3, pages 1573-1587.
Crossref
Crossref
María Tosta Pérez, Lisandra Herrera Belén, Pablo Letelier, Yolanda Calle, Adalberto Pessoa & Jorge G. Farías. (2023) l-Asparaginase as the gold standard in the treatment of acute lymphoblastic leukemia: a comprehensive review. Medical Oncology 40:5.
Crossref
Crossref
Dhaarani Jayaraman, Latha M. Sneha, Gracelin Jeyarani, Alekhya Somayajula, Balaji Thiruvengadam Kothandam, Julius Xavier Scott & A Gadekar. (2023) Experience with Generic Pegylated L-asparaginase in Children with Acute Lymphoblastic Leukemia from a Tertiary Care Oncology Center in South India. South Asian Journal of Cancer.
Crossref
Crossref
Luis Peña Icart, Talita Stelling de Araújo, Marcius da Silva Almeida & Luís Maurício Trambaidi de Rocha e Lima. (2023) Modified Asparaginase for Treatment of Cancer Historical Appraisal and
Future Perspectives. Current Applied Polymer Science 6:1, pages 14-25.
Crossref
Crossref
Carolina Pereira de Souza Melo, Rafael Renatino Canevarolo, Silvia Regina Brandalise, Ana Carolina de Mattos Zeri & José Andrés Yunes. (2023) PERFIL METABOLÔMICO IDENTIFICA ASSOCIAÇÃO DA VIA GLICOLÍTICA COM A RESISTÊNCIA À APARAGINASE EM LINHAGENS CELULARES DE LEUCEMIA LINFOBLÁSTICA AGUDA. Mário Penna Journal 1:1, pages 7-17.
Crossref
Crossref
Yuping Cai, Xinyi Shen, Lingeng Lu, Hong Yan, Huang Huang, Patricia Gaule, Engjel Muca, Casey M. Theriot, Zahra Rattray, Nicholas J. W. Rattray, Jun Lu, Nita Ahuja, Yawei Zhang, Philip B. Paty, Sajid A. Khan & Caroline H. Johnson. (2022) Bile acid distributions, sex-specificity, and prognosis in colorectal cancer. Biology of Sex Differences 13:1.
Crossref
Crossref
Adriana Krupa, Johan de Vos, Lynn Van Eetvelde & Erik Teske. (2022) Pegylated asparaginase in feline high-grade lymphoma: clinical results of single injection and continued incorporation into a modified COP regimen. Journal of Feline Medicine and Surgery 24:8, pages e203-e213.
Crossref
Crossref
Chen-xi Liu, Yun-yu Zhang, Qiu-shi Yang, Shu-hong Shen, Jing Chen, Yan-jing Tang, Chang-cheng Chen, Zhuo Wang, Bi-ru Li, Juan Qian, Ying Wang, Wen-ting Hu & Bo-tao Ning. (2022) Asparaginase-associated pancreatitis in chemotherapy- treated pediatric patients: a five-year retrospective study. World Journal of Emergency Medicine 13:4, pages 313.
Crossref
Crossref
Grace Koo, Sara Anvari, Debra L. Friedman, Sara Zarnegar-Lumley, Vibha Szafron, Basil M. Kahwash, K. Michelle Onasch, Laura Hall, Elizabeth J. Phillips & Cosby A. StoneJr.Jr.. (2022) mRNA COVID-19 vaccine safety in patients with previous immediate hypersensitivity to pegaspargase. The Journal of Allergy and Clinical Immunology: In Practice 10:1, pages 322-325.
Crossref
Crossref
Bing-Mae Chen, Tian-Lu Cheng & Steve R. Roffler. (2021) Polyethylene Glycol Immunogenicity: Theoretical, Clinical, and Practical Aspects of Anti-Polyethylene Glycol Antibodies. ACS Nano 15:9, pages 14022-14048.
Crossref
Crossref
Adesh Baral, Ritesh Gorkhali, Amit Basnet, Shubham Koirala & Hitesh Kumar Bhattarai. (2021) Selection of the Optimal L-asparaginase II Against Acute Lymphoblastic Leukemia: An In Silico Approach. JMIRx Med 2:3, pages e29844.
Crossref
Crossref
Marcela Freitas, Paula Souza, Samuel Cardoso, Kellen Cruvinel, Letícia Santos Abrunhosa, Edivaldo X. Ferreira Filho, João Inácio, Danilo Batista Pinho, Adalberto Pessoa & Pérola O. Magalhães. (2021) Filamentous Fungi Producing l-Asparaginase with Low Glutaminase Activity Isolated from Brazilian Savanna Soil. Pharmaceutics 13:8, pages 1268.
Crossref
Crossref
Xinxin Zhao, Peng Zhang, Yaqi Li, Saizhi Wu, Fengjiao Li, Ying Wang, Songping Liang, Xiao He, Youlin Zeng & Zhonghua Liu. (2021) Glucose–Lipopeptide Conjugates Reveal the Role of Glucose Modification Position in Complexation and the Potential of Malignant Melanoma Therapy. Journal of Medicinal Chemistry 64:15, pages 11483-11495.
Crossref
Crossref
Marcela Helena Gambim Fonseca, Tayná da Silva Fiúza, Stephanie Bath de Morais, Tatiana de Arruda Campos Brasil de Souza & Raphael Trevizani. (2021) Circumventing the side effects of L-asparaginase. Biomedicine & Pharmacotherapy 139, pages 111616.
Crossref
Crossref
Jingyu Zhang, Lan Jiang, Xiangyin Chen, Kangjie Lv, Mostafa Basiony, Guoliang Zhu, Loganathan Karthik, Liming Ouyang, Lixin Zhang & Xueting Liu. (2021) Recent advances in biotechnology for marine enzymes and molecules. Current Opinion in Biotechnology 69, pages 308-315.
Crossref
Crossref
Noura El-Ahmady El-Naggar. 2021. Microbial Cell Factories Engineering for Production of Biomolecules. Microbial Cell Factories Engineering for Production of Biomolecules
183
234
.
Dawn Sijin Nin, Shabana Binte Idres & Lih-Wen Deng. 2021. Oxidative Stress. Oxidative Stress
155
191
.
Trëndelina Rrustemi, Öykü Gönül Geyik, Ali Burak Özkaya, Taylan Kurtuluş Öztürk, Zeynep Yüce & Ali Kılınç. (2020) Acrylamide-encapsulated glucose oxidase inhibits breast cancer cell viability. Turkish Journal of Biochemistry 45:6, pages 811-816.
Crossref
Crossref
Weimin Wang & Weiping Zou. (2020) Amino Acids and Their Transporters in T Cell Immunity and Cancer Therapy. Molecular Cell 80:3, pages 384-395.
Crossref
Crossref
Werner Alfinito Feio de Moura, Leonardo Schultz, Carlos Alexandre Breyer, Ana Laura Pires de Oliveira, Carlos Abrunhosa Tairum, Gabriella Costa Fernandes, Marcos Hikari Toyama, Adalberto Pessoa-Jr, Gisele Monteiro & Marcos Antonio de Oliveira. (2020) Functional and structural evaluation of the antileukaemic enzyme l-asparaginase II expressed at low temperature by different Escherichia coli strains. Biotechnology Letters 42:11, pages 2333-2344.
Crossref
Crossref
Yun-yu Zhang, Qiu-shi Yang, Xia Qing, Bi-ru Li, Juan Qian, Ying Wang & Bo-tao Ning. (2020) Peg-Asparaginase-Associated Pancreatitis in Chemotherapy-Treated Pediatric Patients: A 5-Year Retrospective Study. Frontiers in Oncology 10.
Crossref
Crossref
Hoda M. Soliman, Noura El-A. El-Naggar & Sara M. El-Ewasy. (2020) Bioprocess Optimization for Enhanced Production of L-asparaginase via Two Model-Based Experimental Designs by Alkaliphilic Streptomyces fradiae NEAE-82. Current Biotechnology 9:1, pages 23-37.
Crossref
Crossref
Jean-Michel Rabanel, Philippe Delbreil, Xavier Banquy, Davide Brambilla & Charles Ramassamy. (2020) Periphery-confined particulate systems for the management of neurodegenerative diseases and toxicity: Avoiding the blood-brain-barrier challenge. Journal of Controlled Release 322, pages 286-299.
Crossref
Crossref
Beenish Maqsood, Abdul Basit, Muhammad Khurshid & Qamar Bashir. (2020) Characterization of a thermostable, allosteric L-asparaginase from Anoxybacillus flavithermus. International Journal of Biological Macromolecules 152, pages 584-592.
Crossref
Crossref
Yuping Cai, Nicholas J. W. Rattray, Qian Zhang, Varvara Mironova, Alvaro Santos-Neto, Kuo-Shun Hsu, Zahra Rattray, Justin R. Cross, Yawei Zhang, Philip B. Paty, Sajid A. Khan & Caroline H. Johnson. (2020) Sex Differences in Colon Cancer Metabolism Reveal A Novel Subphenotype. Scientific Reports 10:1.
Crossref
Crossref
Xingdi Hu, Kingsley P. Wildman, Subham Basu, Peggy L. Lin, Clare Rowntree & Vaskar Saha. (2019) The cost-effectiveness of pegaspargase versus native asparaginase for first-line treatment of acute lymphoblastic leukaemia: a UK-based cost-utility analysis. Health Economics Review 9:1.
Crossref
Crossref
Yoko Tabe, Philip L. Lorenzi & Marina Konopleva. (2019) Amino acid metabolism in hematologic malignancies and the era of targeted therapy. Blood 134:13, pages 1014-1023.
Crossref
Crossref
Noura El-Ahmady El-Naggar, Hassan Moawad, Nancy M. El-Shweihy, Sara M. El-Ewasy, Islam A. Elsehemy & Nayera A. M. Abdelwahed. (2019) Process development for scale-up production of a therapeutic L-asparaginase by Streptomyces brollosae NEAE-115 from shake flasks to bioreactor. Scientific Reports 9:1.
Crossref
Crossref
Gertjan J. L. Kaspers. (2019) Acute myeloid leukaemia niche regulates response to L‐asparaginase. British Journal of Haematology 186:3, pages 397-399.
Crossref
Crossref
Fernanda Furlan Gonçalves Dias, Jessika Gonçalves dos Santos Aguilar & Helia Harumi Sato. (2019) l-Asparaginase from Aspergillus spp.: production based on kinetics, thermal stability and biochemical characterization. 3 Biotech 9:7.
Crossref
Crossref
Xu Li, Shuqin Xu, Xian Zhang, Meijuan Xu, Taowei Yang, Li Wang, Huiling Zhang, Haitian Fang, Tolbert Osire, Shangtian Yang & Zhiming Rao. (2019)
Design of a high‐efficiency synthetic system for
l
‐asparaginase production in
Bacillus subtilis
. Engineering in Life Sciences 19:3, pages 229-239.
Crossref
Crossref
Tania Paul, Abhijit Mondal & Tarun Kanti Bandyopadhyay. (2019) Isolation, Purification, Characterisation and Application of L-ASNase: A Review. Recent Patents on Biotechnology 13:1, pages 33-44.
Crossref
Crossref
D. V. Borsakova & E. I. Sinauridze. (2019) L-asparaginase: new approaches to improve pharmacological characteristics. Pediatric Hematology/Oncology and Immunopathology 17:4, pages 82-99.
Crossref
Crossref
Larissa Pereira Brumano, Francisco Vitor Santos da Silva, Tales Alexandre Costa-Silva, Alexsandra Conceição Apolinário, João Henrique Picado Madalena Santos, Eduardo Krebs Kleingesinds, Gisele Monteiro, Carlota de Oliveira Rangel-Yagui, Brahim Benyahia & Adalberto Pessoa Junior. (2019) Development of L-Asparaginase Biobetters: Current Research Status and Review of the Desirable Quality Profiles. Frontiers in Bioengineering and Biotechnology 6.
Crossref
Crossref
Madhuri Pola, Satish Babu Rajulapati, Chandrasai Potla Durthi, Rajeswara Reddy Erva & Mayuri Bhatia. (2018) In silico modelling and molecular dynamics simulation studies on L-Asparaginase isolated from bacterial endophyte of Ocimum tenuiflorum. Enzyme and Microbial Technology 117, pages 32-40.
Crossref
Crossref
Rajesh Kumar Kante, Sandeep Vemula, Maheswara Reddy Mallu & Srinivasa Reddy Ronda. (2018)
Efficient and easily scalable protein folding strong anion exchange chromatography for renaturation and simultaneous purification of recombinant human asparaginase from
E. coli
. Biotechnology Progress 34:4, pages 1036-1044.
Crossref
Crossref
Xu Li, Xian Zhang, Shuqin Xu, Hengwei Zhang, Meijuan Xu, Taowei Yang, Li Wang, Haifeng Qian, Huiling Zhang, Haitian Fang, Tolbert Osire, Zhiming Rao & Shangtian Yang. (2018) Simultaneous cell disruption and semi-quantitative activity assays for high-throughput screening of thermostable L-asparaginases. Scientific Reports 8:1.
Crossref
Crossref
Anil Kamat. (2018) Retrospective post-marketing study on the use of bio-similar pegasparagase among acute lymphoblastic leukemia patients in India. Pediatric Hematology Oncology Journal 3:1, pages 9-12.
Crossref
Crossref
Paula Monteiro Souza, Marcela Medeiros de Freitas, Samuel Leite Cardoso, Adalberto Pessoa, Eliete Neves Silva Guerra & Pérola Oliveira Magalhães. (2017) Optimization and purification of l -asparaginase from fungi: A systematic review. Critical Reviews in Oncology/Hematology 120, pages 194-202.
Crossref
Crossref
Rong Liang, Guang-xun Gao, Jie-ping Chen, Ji-shi Wang, Xiao-min Wang, Yun Zeng, Qing-xian Bai, Tao Zhang, Lan Yang, Bao-xia Dong, Hong-tao Gu, Mi-mi Shu, Cai-xia Hao, Jian-hong Wang, Na Zhang & Xie-qun Chen. (2017) A phase 2 study of methotrexate, etoposide, dexamethasone, and pegaspargase chemotherapy for newly diagnosed, relapsed, or refractory extranodal natural killer/T-cell lymphoma, nasal type: a multicenter trial in Northwest China. Hematological Oncology 35:4, pages 619-629.
Crossref
Crossref
João H. P. M. Santos, Iris M. Costa, João V. D. Molino, Mariana S. M. Leite, Marcela V. Pimenta, João A. P. Coutinho, Adalberto PessoaJrJr, Sónia P. M. Ventura, André M. Lopes & Gisele Monteiro. (2017)
Heterologous expression and purification of active L-asparaginase I of
Saccharomyces cerevisiae
in
Escherichia coli
host
. Biotechnology Progress 33:2, pages 416-424.
Crossref
Crossref
João H. P. M. Santos, Gustavo Carretero, João A. P. Coutinho, Carlota O. Rangel-Yagui & Sónia P. M. Ventura. (2017) Multistep purification of cytochrome c PEGylated forms using polymer-based aqueous biphasic systems. Green Chemistry 19:24, pages 5800-5808.
Crossref
Crossref
Carla S. Silva Teixeira, Henrique S. Fernandes, Pedro A. Fernandes, Maria J. Ramos & Nuno M.F.S.A. Cerqueira. 2017. Nanostructures for Cancer Therapy. Nanostructures for Cancer Therapy
623
651
.
S.J. Park, B.H. Lui & J.R. Cochran. 2017. Comprehensive Biomaterials II. Comprehensive Biomaterials II
221
247
.
Jorge Javier Muso Cachumba, Felipe Antonio Fernandes Antunes, Guilherme Fernando Dias Peres, Larissa Pereira Brumano, Júlio César Dos Santos & Silvio Silvério Da Silva. (2016) Current applications and different approaches for microbial l-asparaginase production. Brazilian Journal of Microbiology 47, pages 77-85.
Crossref
Crossref
Erva Rajeswara Reddy, Rajulapati Satish Babu, Potla Durthi Chandrasai & Pola Madhuri. (2016) Exploration of the binding modes of l-asparaginase complexed with its amino acid substrates by molecular docking, dynamics and simulation. 3 Biotech 6:1.
Crossref
Crossref
Rajeswara Reddy Erva, Satish Babu Rajulapati, Chandrasai Potla Durthi, Mayuri Bhatia & Madhuri Pola. (2015) Molecular dynamic simulations of Escherichia coli l-asparaginase to illuminate its role in deamination of asparagine and glutamine residues. 3 Biotech 6:1.
Crossref
Crossref
Abhinav Shrivastava, Abdul Arif Khan, Mohsin Khurshid, Mohd Abul Kalam, Sudhir K. Jain & Pradeep K. Singhal. (2016) Recent developments in l-asparaginase discovery and its potential as anticancer agent. Critical Reviews in Oncology/Hematology 100, pages 1-10.
Crossref
Crossref
Peter L. Turecek, Mary J. Bossard, Freddy Schoetens & Inge A. Ivens. (2016) PEGylation of Biopharmaceuticals: A Review of Chemistry and Nonclinical Safety Information of Approved Drugs. Journal of Pharmaceutical Sciences 105:2, pages 460-475.
Crossref
Crossref
C. John, T. Herz, J. Boos, K. Langer & G. Hempel. (2016) Asymmetrical flow field-flow fractionation for the analysis of PEG-asparaginase. Talanta 146, pages 335-339.
Crossref
Crossref
Usman Ali, Muhammad Naveed, Abid Ullah, Khadija Ali, Sayed Afzal Shah, Shah Fahad & Abdul Samad Mumtaz. (2016) L-asparaginase as a critical component to combat Acute Lymphoblastic Leukaemia (ALL): A novel approach to target ALL. European Journal of Pharmacology 771, pages 199-210.
Crossref
Crossref
K. Doriya, N. Jose, M. Gowda & D.S. Kumar. 2016. Marine Enzymes Biotechnology: Production and Industrial Applications, Part I - Production of Enzymes. Marine Enzymes Biotechnology: Production and Industrial Applications, Part I - Production of Enzymes
115
135
.
Zuzana Ciesarová. 2016. Acrylamide in Food. Acrylamide in Food
405
421
.
Fernanda Furlan Gonçalves Dias, Ruann Janser Soares de Castro, André Ohara, Tânia Goia Nishide, Marcela Pavan Bagagli & Hélia Harumi Sato. (2015) Simplex centroid mixture design to improve l -asparaginase production in solid-state fermentation using agroindustrial wastes. Biocatalysis and Agricultural Biotechnology 4:4, pages 528-534.
Crossref
Crossref
Fatemeh Mottaghitalab, Mehdi Farokhi, Mohammad Ali Shokrgozar, Fatemeh Atyabi & Hossein Hosseinkhani. (2015) Silk fibroin nanoparticle as a novel drug delivery system. Journal of Controlled Release 206, pages 161-176.
Crossref
Crossref
Christos S Karamitros & Nikolaos E Labrou. (2014) Extracellular expression and affinity purification of L-asparaginase from E. chrysanthemi in E. coli. Sustainable Chemical Processes 2:1.
Crossref
Crossref
Betiana Felice, Molamma P. Prabhakaran, Andrea P. Rodríguez & Seeram Ramakrishna. (2014) Drug delivery vehicles on a nano-engineering perspective. Materials Science and Engineering: C 41, pages 178-195.
Crossref
Crossref
Sandra Liebscher, Petra Kornberger, Gerhard Fink, Eva-Maria Trost-Gross, Eva H?ss, Arne Skerra & Frank Bordusa. (2014) Derivatization of Antibody Fab Fragments: A Designer Enzyme for Native Protein Modification. ChemBioChem 15:8, pages 1096-1100.
Crossref
Crossref
Noura El-Ahmady El-Nagga, Sara M. El-Ewasy & Nancy M. El-Shweihy. (2014) Microbial L-asparaginase as a Potential Therapeutic Agent for the Treatment of Acute Lymphoblastic Leukemia: The Pros and Cons. International Journal of Pharmacology 10:4, pages 182-199.
Crossref
Crossref
Amanda M. Schalk & Arnon Lavie. (2014)
Structural and Kinetic Characterization of Guinea Pig
l
-Asparaginase Type III
. Biochemistry 53:14, pages 2318-2328.
Crossref
Crossref
Yogendra Singh & S. K. Srivastava. (2014)
Performance improvement of
Bacillus aryabhattai
ITBHU02 for high-throughput production of a tumor-inhibitory L-asparaginase using a kinetic model based approach
. Journal of Chemical Technology & Biotechnology 89:1, pages 117-127.
Crossref
Crossref
Umit M. Sahiner, S. Tolga Yavuz, Muge G?kce, Betul Buyuktiryaki, Ilhan Altan, Selin Aytac, Murat Tuncer, Ayfer Tuncer & Cansin Sackesen. (2013) Anaphylactic reaction to polyethylene-glycol conjugated-asparaginase: Premedication and desensitization may not be sufficient. Pediatrics International 55:4, pages 531-533.
Crossref
Crossref
H. Kamada & S.-I. Tsunoda. 2013. Biomaterials for Cancer Therapeutics. Biomaterials for Cancer Therapeutics
95
112
.
Lorenz Meinel & David L. Kaplan. (2012) Silk constructs for delivery of musculoskeletal therapeutics. Advanced Drug Delivery Reviews 64:12, pages 1111-1122.
Crossref
Crossref
Tian-Lu Cheng, Kuo-Hsiang Chuang, Bing-Mae Chen & Steve R. Roffler. (2012) Analytical Measurement of PEGylated Molecules. Bioconjugate Chemistry 23:5, pages 881-899.
Crossref
Crossref
Saurabh Bansal, Ankit Srivastava, Goutam Mukherjee, Ramendra Pandey, Anita Kamra Verma, Prashant Mishra & Bishwajit Kundu. (2011) Hyperthermophilic asparaginase mutants with enhanced substrate affinity and antineoplastic activity: structural insights on their mechanism of action. The FASEB Journal 26:3, pages 1161-1171.
Crossref
Crossref
Abhinav Shrivastava, Abdul Arif Khan, S. K. Jain & P. K. Singhal. 2012. Bacteria and Cancer. Bacteria and Cancer
225
244
.
Preeti Chanalia, Dimpi Gandhi, Drukshakshi Jodha & Jasbir Singh. (2011) Applications of microbial proteases in pharmaceutical industry. Reviews in Medical Microbiology 22:4, pages 96-101.
Crossref
Crossref
Narkhyun Bae, Arnold Pollak & Gert Lubec. (2011)
Proteins from Erwinia asparaginase Erwinase
®
and E. coli asparaginase 2 MEDAC
®
for treatment of human leukemia, show a multitude of modifications for which the consequences are completely unclear
. ELECTROPHORESIS 32:14, pages 1824-1828.
Crossref
Crossref
Teerapol Srichana & Tan Suwandecha. 2011. Biodegradable Polymers in Clinical Use and Clinical Development. Biodegradable Polymers in Clinical Use and Clinical Development
451
493
.
Yu-Qing Zhang, Yuan-Jing Wang, Hai-Yan Wang, Lin Zhu & Zhen-Zhen Zhou. (2011) Highly efficient processing of silk fibroin nanoparticle-l-asparaginase bioconjugates and their characterization as a drug delivery system. Soft Matter 7:20, pages 9728.
Crossref
Crossref
B.H. Lui & J.R. Cochran. 2011. Comprehensive Biomaterials. Comprehensive Biomaterials
161
179
.
Steven W Paugh, Gabriele Stocco & William E Evans. (2010) Pharmacogenomics in pediatric leukemia. Current Opinion in Pediatrics 22:6, pages 703-710.
Crossref
Crossref
Claudia Scotti, Patrizia Sommi, Maria Valentina Pasquetto, Donata Cappelletti, Simona Stivala, Paola Mignosi, Monica Savio, Laurent Roberto Chiarelli, Giovanna Valentini, Victor M. Bolanos-Garcia, Douglas Scott Merrell, Silvia Franchini, Maria Luisa Verona, Cristina Bolis, Enrico Solcia, Rachele Manca, Diego Franciotta, Andrea Casasco, Paola Filipazzi, Elisabetta Zardini & Vanio Vannini. (2010) Cell-Cycle Inhibition by Helicobacter pylori L-Asparaginase. PLoS ONE 5:11, pages e13892.
Crossref
Crossref
Georgia A. Kotzia & Nikolaos E. Labrou. (2009)
Engineering thermal stability of
l‐
asparaginase by
in vitro
directed evolution
. The FEBS Journal 276:6, pages 1750-1761.
Crossref
Crossref
Donata Cappelletti, Laurent R. Chiarelli, Maria Valentina Pasquetto, Simona Stivala, Giovanna Valentini & Claudia Scotti. (2008) Helicobacter pyloril-asparaginase: A promising chemotherapeutic agent. Biochemical and Biophysical Research Communications 377:4, pages 1222-1226.
Crossref
Crossref
Maisie Lo, Yu-Zhuo Wang & Peter W. Gout. (2008) The xc− cystine/glutamate antiporter: A potential target for therapy of cancer and other diseases. Journal of Cellular Physiology 215:3, pages 593-602.
Crossref
Crossref
Jian‐Hang Zhu & Juan Liu. (2008)
Improving the extraction of intracellular
L
‐asparaginase by high‐pressure homogenization
. Asia-Pacific Journal of Chemical Engineering 3:2, pages 211-216.
Crossref
Crossref
E Tavernier, J-M Boiron, F Huguet, K Bradstock, N Vey, T Kovacsovics, A Delannoy, N Fegueux, P Fenaux, A Stamatoullas, O Tournilhac, A Buzyn, O Reman, C Charrin, C Boucheix, J Gabert, V Lhéritier, J-P Vernant, H Dombret & X Thomas. (2007) Outcome of treatment after first relapse in adults with acute lymphoblastic leukemia initially treated by the LALA-94 trial. Leukemia 21:9, pages 1907-1914.
Crossref
Crossref
Georgia A. Kotzia, Katerina Lappa & Nikolaos E. Labrou. (2007) Tailoring structure–function properties of L-asparaginase: engineering resistance to trypsin cleavage. Biochemical Journal 404:2, pages 337-343.
Crossref
Crossref
Meir WetzlerBen L. SanfordJoanne KurtzbergDivino DeOliveiraStanley R. FrankelBayard L. PowellJonathan E. KolitzClara D. BloomfieldRichard A. Larson. (2007) Effective asparagine depletion with pegylated asparaginase results in improved outcomes in adult acute lymphoblastic leukemia: Cancer and Leukemia Group B Study 9511. Blood 109:10, pages 4164-4167.
Crossref
Crossref
Dan Douer, Henry Yampolsky, Lewis J. Cohen, Kristy Watkins, Alexandra M. Levine, Antonia P. Periclou & Vassilios I. Avramis. (2006) Pharmacodynamics and safety of intravenous pegaspargase during remission induction in adults aged 55 years or younger with newly diagnosed acute lymphoblastic leukemia. Blood 109:7, pages 2744-2750.
Crossref
Crossref
Jian-Hang Zhu, Xi-Luan Yan, Hong-Jun Chen & Zhi-Hui Wang. (2007) In situ extraction of intracellular l-asparaginase using thermoseparating aqueous two-phase systems. Journal of Chromatography A 1147:1, pages 127-134.
Crossref
Crossref
Umesh K. Narta, Shamsher S. Kanwar & Wamik Azmi. (2007) Pharmacological and clinical evaluation of l-asparaginase in the treatment of leukemia. Critical Reviews in Oncology/Hematology 61:3, pages 208-221.
Crossref
Crossref
Vishal S. Narang, Giovanni M. Pauletti, Peter W. Gout, Donna J. Buckley & Arthur R. Buckley. (2007) Sulfasalazine-Induced Reduction of Glutathione Levels in Breast Cancer Cells: Enhancement of Growth-Inhibitory Activity of Doxorubicin. Chemotherapy 53:3, pages 210-217.
Crossref
Crossref
Georgia A. Kotzia & Nikolaos E. Labrou. (2007) l-Asparaginase from Erwinia Chrysanthemi 3937: Cloning, expression and characterization. Journal of Biotechnology 127:4, pages 657-669.
Crossref
Crossref
Yu-Qing Zhang, Mei-Lin Tao, Wei-De Shen, Jian-Ping Mao & Yu-hua Chen. (2006) Synthesis of silk sericin peptides-L-asparaginase bioconjugates and their characterization. Journal of Chemical Technology & Biotechnology 81:2, pages 136-145.
Crossref
Crossref
J.P. Vieira Pinheiro, K. Wenner, G. Escherich, C. Lanvers-Kaminsky, G. Würthwein, G. Janka-Schaub & J. Boos. (2006) Serum asparaginase activities and asparagine concentrations in the cerebrospinal fluid after a single infusion of 2,500 IU/m2 PEG asparaginase in children with ALL treated according to protocol COALL-06-97. Pediatric Blood & Cancer 46:1, pages 18-25.
Crossref
Crossref
Yu-Qing Zhang, Wei-Lin Zhou, Wei-De Shen, Yu-Hua Chen, Xin-Min Zha, Koji Shirai & Kenji Kiguchi. (2005) Synthesis, characterization and immunogenicity of silk fibroin-l-asparaginase bioconjugates. Journal of Biotechnology 120:3, pages 315-326.
Crossref
Crossref
Valerie S. MacDonald, Douglas H. Thamm, Ilene D. Kurzman, Michelle M. Turek & David M. Vail. (2005) Does l-Asparaginase Influence Efficacy or Toxicity When Added to a Standard CHOP Protocol for Dogs with Lymphoma?. Journal of Veterinary Internal Medicine 19:5, pages 732-736.
Crossref
Crossref
Diana A. Averill-Bates, Anissa Chérif, Enzo Agostinelli, André Tanel & Guy Fortier. (2005) Anti-tumoral effect of native and immobilized bovine serum amine oxidase in a mouse melanoma model. Biochemical Pharmacology 69:12, pages 1693-1704.
Crossref
Crossref
Maria Inez de Moura Sarquis, Edna Maria Morais Oliveira, Alberdan Silva SantosGisela Lara da Costa. (2004) Production of L-asparaginase by filamentous fungi. Mem?rias do Instituto Oswaldo Cruz 99:5, pages 489-492.
Crossref
Crossref
Tamotsu Irino, Toshiyuki Kitoh, Kenichi Koami, Terumi Kashima, Kouichi Mukai, Eiji Takeuchi, Teruaki Hongo, Tatsutoshi Nakahata, Sheldon M. Schuster & Mitsuhiko Osaka. (2004) Establishment of Real-Time Polymerase Chain Reaction Method for Quantitative Analysis of Asparagine Synthetase Expression. The Journal of Molecular Diagnostics 6:3, pages 217-224.
Crossref
Crossref
Ashraf A. El-Bessoumy, Mohamed Sarhan & Jehan Mansour. (2004) Production, Isolation, and Purification of L-Asparaginase from Pseudomonas Aeruginosa 50071 Using Solid-state Fermentation. BMB Reports 37:4, pages 387-393.
Crossref
Crossref
L J Hak, M V Relling, C Cheng, D Pei, B Wang, J T Sandlund, J Rubnitz & C-H Pui. (2004) Asparaginase pharmacodynamics differ by formulation among children with newly diagnosed acute lymphoblastic leukemia. Leukemia 18:6, pages 1072-1077.
Crossref
Crossref
K Hoste, K De Winne & E Schacht. (2004) Polymeric prodrugs. International Journal of Pharmaceutics 277:1-2, pages 119-131.
Crossref
Crossref
João Paulo Vieira Pinheiro & Joachim Boos. (2004) The best way to use asparaginase in childhood acute lymphatic leukaemia – still to be defined?. British Journal of Haematology 125:2, pages 117-127.
Crossref
Crossref
Sushma Kommareddy & Mansoor Amiji. 2004. Cellular Drug Delivery. Cellular Drug Delivery
181
215
.
B Wang, M V Relling, M C Storm, M H Woo, R Ribeiro, C-H Pui & L J Hak. (2003) Evaluation of immunologic crossreaction of antiasparaginase antibodies in acute lymphoblastic leukemia (ALL) and lymphoma patients. Leukemia 17:8, pages 1583-1588.
Crossref
Crossref
Yoko Yamamoto, Yasuo Tsutsumi, Yasuo Yoshioka, Toshihide Nishibata, Kyoko Kobayashi, Takayuki Okamoto, Yohei Mukai, Tomoe Shimizu, Shinsaku Nakagawa, Satoshi Nagata & Tadanori Mayumi. (2003) Site-specific PEGylation of a lysine-deficient TNF-α with full bioactivity. Nature Biotechnology 21:5, pages 546-552.
Crossref
Crossref
J. Milton Harris & Robert B. Chess. (2003) Effect of pegylation on pharmaceuticals. Nature Reviews Drug Discovery 2:3, pages 214-221.
Crossref
Crossref
Deborah A Thomas, Jorge Cortes & Hagop M Kantarjian. (2002) New agents in the treatment of acute lymphocytic leukaemia. Best Practice & Research Clinical Haematology 15:4, pages 771-790.
Crossref
Crossref
Claudia Lanvers, Joao Paulo Vieira Pinheiro, Georg Hempel, Gudrun Wuerthwein & Joachim Boos. (2002) Analytical validation of a microplate reader-based method for the therapeutic drug monitoring of l-asparaginase in human serum. Analytical Biochemistry 309:1, pages 117-126.
Crossref
Crossref
P?ivi Ylikangas & Ilkka Mononen. (2002) Serious Neutropenia in ALL Patients Treated With L-Asparaginase May Be Avoided by Therapeutic Monitoring of the Enzyme Activity in the Circulation. Therapeutic Drug Monitoring 24:4, pages 502-506.
Crossref
Crossref
Hiroyuki Sakakibara, Takashi Tamura, Takehiko Suzuki, Tomohiro Hisano, Shiro Abe & Kousaku Murata. (2002) Preparation and Properties of Alginate Lyase Modified with Poly(Ethylene Glycol). Journal of Pharmaceutical Sciences 91:4, pages 1191-1199.
Crossref
Crossref
Vassilios I. AvramisSusan SencerAntonia P. PericlouHarland SatherBruce C. BostromLewis J. CohenAlice G. EttingerLawrence J. EttingerJanet FranklinPaul S. GaynonJoanne M. HildenBeverly LangeFataneh MajlessipourPracad MathewMichael NeedleJoseph NegliaGregory ReamanJohn S. Holcenberg. (2002) A randomized comparison of nativeEscherichia coli asparaginase and polyethylene glycol conjugated asparaginase for treatment of children with newly diagnosed standard-risk acute lymphoblastic leukemia: a Children's Cancer Group study. Blood 99:6, pages 1986-1994.
Crossref
Crossref
Helen A. Kurre, Alice G. Ettinger, David L. Veenstra, Paul S. Gaynon, Janet Franklin, Susan F. Sencer, Gregory H. Reaman, Beverly J. Lange & John S. Holcenberg. (2002) A Pharmacoeconomic Analysis of Pegaspargase Versus Native Escherichia Coli l-Asparaginase for the Treatment of Children With Standard-Risk, Acute Lymphoblastic Leukemia: The Children's Cancer Group Study (CCG-1962). Journal of Pediatric Hematology/Oncology 24:3, pages 175-181.
Crossref
Crossref
PW Gout, AR Buckley, CR Simms & N Bruchovsky. (2001) Sulfasalazine, a potent suppressor of lymphoma growth by inhibition of the xc − cystine transporter: a new action for an old drug. Leukemia 15:10, pages 1633-1640.
Crossref
Crossref
Michelle J. Ferguson, Fareeda Y. Ahmed & Jim Cassidy. (2001) The role of pro-drug therapy in the treatment of cancer. Drug Resistance Updates 4:4, pages 225-232.
Crossref
Crossref
Ana I Fernandes & Gregory Gregoriadis. (2001) The effect of polysialylation on the immunogenicity and antigenicity of asparaginase: implication in its pharmacokinetics. International Journal of Pharmaceutics 217:1-2, pages 215-224.
Crossref
Crossref
Guillermo Garcia-Manero & Deborah A. Thomas. (2001) Salvage Therapy for Refractory or Relapsed Acute Lymphocytic Leukemia. Hematology/Oncology Clinics of North America 15:1, pages 163-205.
Crossref
Crossref
James F. Eliason. (2001) Pegylated Cytokines. BioDrugs 15:11, pages 705-711.
Crossref
Crossref
Thomas C. AbshireBrad H. PollockAmy L. BillettPatricia BradleyGeorge R. Buchanan. (2000) Weekly polyethylene glycol conjugated L-asparaginase compared with biweekly dosing produces superior induction remission rates in childhood relapsed acute lymphoblastic leukemia: a pediatric oncology group study. Blood 96:5, pages 1709-1715.
Crossref
Crossref
Li Guo, Jinhua Wang, Xiyun Yan, Runsheng Chen, Shijun Qian & Guangzhen Meng. (2000) Characterization of -Asparaginase Fused with a Protective ScFv and the Protection Mechanism. Biochemical and Biophysical Research Communications 276:1, pages 197-203.
Crossref
Crossref
Hans‐Joachim Müller, Lutz Löning, Alexander Horn, Dirk Schwabe, Martin Gunkel, Martin Schrappe, Volker Von Schütz, Günter Henze, João Casimiro da Palma, Jörg Ritter, João Paulo Vieira Pinheiro, Monika Winkelhorst & Joachim Boos. (2001)
Pegylated asparaginase (Oncaspar
TM
) in children with ALL: drug monitoring in reinduction according to the ALL/NHL‐BFM 95 protocols
. British Journal of Haematology 110:2, pages 379-384.
Crossref
Crossref
K Rajender Reddy. (2016) Controlled-Release, Pegylation, Liposomal Formulations: New Mechanisms in the Delivery of Injectable Drugs. Annals of Pharmacotherapy 34:7-8, pages 915-923.
Crossref
Crossref
P?ivi Ylikangas & Ilkka Mononen. (2000) A Fluorometric Assay for -Asparaginase Activity and Monitoring of -Asparaginase Therapy. Analytical Biochemistry 280:1, pages 42-45.
Crossref
Crossref
Ofelia A. Alvarez & Grenith Zimmerman. (2000) Pegaspargase-induced pancreatitis. Medical and Pediatric Oncology 34:3, pages 200-205.
Crossref
Crossref
Hagop M. KantarjianSusan O’BrienTerry L. SmithJorge CortesFrancis J. GilesMiloslav BeranSherry PierceYang HuhMichael AndreeffCharles KollerChul S. HaMichael J. KeatingSharon MurphyEmil J. Freireich. (2000) Results of Treatment With Hyper-CVAD, a Dose-Intensive Regimen, in Adult Acute Lymphocytic Leukemia. Journal of Clinical Oncology 18:3, pages 547-547.
Crossref
Crossref
T.C. Fisher. (2000) PEG-coated red blood cells— simplifying blood transfusion in the new millennium?. Immunohematology 16:1, pages 37-48.
Crossref
Crossref
James F. Eliason, Anthony Greway, Nadine Tare, Tomoaki Inoue, Sharon Bowen, Marilyn Dar, Motoo Yamasaki, Masami Okabe & Ikuo Horii. (2009) Extended Activity in Cynomolgus Monkeys of a Granulocyte Colony‐Stimulating Factor Mutein Conjugated With High Molecular Weight Polyethylene Glycol. STEM CELLS 18:1, pages 40-45.
Crossref
Crossref
Sharon Bowen, Nadine Tare, Tomoaki Inoue, Motoo Yamasaki, Masami Okabe, Ikuo Horii & James F Eliason. (1999) Relationship between molecular mass and duration of activity of polyethylene glycol conjugated granulocyte colony-stimulating factor mutein. Experimental Hematology 27:3, pages 425-432.
Crossref
Crossref
M. L. Nucci, R. G. L. Shorr & A. Abuchowski. 1999. Novel Therapeutics from Modern Biotechnology. Novel Therapeutics from Modern Biotechnology
59
88
.
D. E. Leckband, O. V. Borisov & A. Halperin. (1998) Cold and Hot Denaturation of Polysoaps. Macromolecules 31:7, pages 2368-2374.
Crossref
Crossref
Gregory Gregoriadis, Ana Fernandes, Brenda McCormack, Malini Mital & Xiaoqin Zhang. 1998. Targeting of Drugs 6. Targeting of Drugs 6
193
205
.
Ana I Fernandes & Gregory Gregoriadis. (1997) Polysialylated asparaginase: preparation, activity and pharmacokinetics. Biochimica et Biophysica Acta (BBA) - Protein Structure and Molecular Enzymology 1341:1, pages 26-34.
Crossref
Crossref
Ronald M. Friedman, Ildiko Gyimesi, Jack B. RobinsonJr.Jr. & Rod J. Rohrich. (1996) Saline Made Viscous with Polyethylene Glycol: A New Alternate Breast Implant Filler Material. Plastic & Reconstructive Surgery 98:7, pages 1208-1213.
Crossref
Crossref
Sanjay S. Patel & Paul Benfield. (2012) Pegaspargase (Polyethylene Glycol-L-Asparaginase). Clinical Immunotherapeutics 5:6, pages 492-496.
Crossref
Crossref
Beverly A. Teicher, Gulshan Ara, Ying-nan Chen, Yasunori Emi, Yoshihiro Kakeji, Masahiko Ikebe & Yoshihiko Maehara. (1996) PEG-Hemoglobin:Effects on tumor oxygenation and radiosensitization. Radiation Oncology Investigations 4:5, pages 200-210.
Crossref
Crossref
Xue-Min Cheng. 1995.
295
317
.
C.J. van Boxtel. 1994.
319
324
.